Previous close | 1,854.00 |
Open | 1,861.00 |
Bid | 1,913.00 x 0 |
Ask | 1,915.00 x 0 |
Day's range | 1,861.00 - 1,920.00 |
52-week range | 1,711.00 - 2,222.00 |
Volume | |
Avg. volume | 629,221 |
Market cap | 4.245B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 28.13 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.57 (3.07%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.